Personalised Medicine in a Post-Genomic Era
Publisher
Springer Singapore
Reference37 articles.
1. Barnes, B., & Dupré, J. (2008). Genomes and What to Make of Them. London: University of Chicago Press. 2. Borup, M., Brown, N., Konrad, K., & Van Lente, H. (2006). The Sociology of Expectations in Science and Technology. Technological Analysis and Strategic Management, 18(3), 285–298. 3. Crinson, I. (2004). The Politics of Regulation within the ‘Modernised’ NHS: The Case of Beta Interferon & the ‘Cost-Effective’ Treatment of Multiple Sclerosis. Critical Social Policy, 24(1), 30–49. 4. Denny, J., Rutter, J., Goldstein, D., Philippakis, A., Smoller, J., Jenkins, J., & Dishman, E. (2019). The ‘All of US’ Research Program. The New England Journal of Medicine, 381, 668–676. 5. Dumit, J. (2012). Drugs for Life: How Pharmaceutical Companies Define Our Health. Durham & London: Duke University Press.
|
|